Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-23

Clinical Trial Update: Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) [Phase 4]

View source ↗

Summary

A Phase 4 trial updating on the microvascular angina intervention using Compound Danshen Dripping Pill (MAIDS) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Compound Danshen Dripping Pill

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Microvascular Angina | Phase 4 | Status: RECRUITING